H.R. 8816 · 118th Congress
American Medical Innovation and Investment Act of 2024
Introduced on Jun 25, 2024 by Vern Buchanan (R-FL-16). Latest action (Dec 27, 2024): Reported (Amended) by the Committee on Ways and Means. H. Rept. 118-958, Part I.
- Stage
- Reported by committee
- Introduced
- Jun 25, 2024
- Cosponsors
- 0
- Policy area
- Health
Progress
The furthest stage the measure reached. Simple and concurrent resolutions do not go to the President.
- Introduced
- Reported by committee
- 3Passed one chamber
- 4Passed both chambers
- 5Sent to the President
- 6Became law
Official title
To amend title XVIII of the Social Security Act to provide for a cognitive impairment detection benefit under the Medicare program, and for other purposes.
Subjects
- Advanced technology and technological innovations
- Congressional oversight
- Government information and archives
- Health care costs and insurance
- Health care coverage and access
- Health promotion and preventive care
- Health technology, devices, supplies
- Home and outpatient care
- Medicare
- Neurological disorders
- Prescription drugs
Summary
The Congressional Research Service has not summarized this measure yet.
Sponsor and cosponsors
Cosponsors by party as of the day they signed on. Original cosponsors signed on the day of introduction.
No cosponsors.
Roll calls
Recorded votes on the measure. Most measures move by voice vote or unanimous consent, which record no individual positions.
No recorded roll call on this measure: it moved by voice vote or unanimous consent, or has not reached the floor.
History
Every action as published, oldest first. Roll calls link to how each member voted.
- Jun 25, 2024Introduced in House
- Jun 25, 2024Introduced in House
- Jun 25, 2024 · HouseReferred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
- Jun 25, 2024 · HouseReferred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
- Jun 27, 2024 · HouseCommittee Consideration and Mark-up Session Held
- Jun 27, 2024 · HouseOrdered to be Reported in the Nature of a Substitute (Amended) by the Yeas and Nays: 40 - 0.
- Dec 27, 2024Reported (Amended) by the Committee on Ways and Means. H. Rept. 118-958, Part I.
- Dec 27, 2024 · HouseReported (Amended) by the Committee on Ways and Means. H. Rept. 118-958, Part I.
Committees
Committees and subcommittees the measure was referred to.
Agencies in its committees' jurisdiction
Analisa's mapping of committee jurisdiction to federal agencies; the bill may touch others, or none of these.
Who lobbied on it
Organizations whose lobbying reports (LD-2) name this measure. Spending is what they reported for those quarters on all issues, not on this measure alone.
- ALNYLAM PHARMACEUTICALS, INC.5 reports
- PFIZER INC.5 reports
- CHIESI USA, INC.3 reports
- DIGITAL THERAPEUTICS ALLIANCE, INC3 reports
- EDWARDS LIFESCIENCES3 reports
- Food Fix Campaign Action, Inc.3 reports$300K reported (all issues)
- Food Is Medicine Coalition3 reports$60K reported (all issues)
- GE HEALTHCARE TECHNOLOGIES INC.3 reports$490K reported (all issues)
- MASSACHUSETTS MEDICAL SOCIETY3 reports$160K reported (all issues)
- Alliance for Aging Research2 reports$240K reported (all issues)
- American Geriatrics Society2 reports$40K reported (all issues)
- Caris Science Inc2 reports$80K reported (all issues)
- ABBVIE1 report$1.1M reported (all issues)Federal contractor: ABBVIE US LLC$154.6K in contracts, FY2026AI match · 100%
- American Medical Association1 report$5.1M reported (all issues)Federal contractor: AMERICAN MEDICAL ASSOCIATION$371K in contracts, FY2026AI match · 99%
- UNITED SEATING AND MOBILITY LLC1 report$30K reported (all issues)Federal contractor: UNITED SEATING AND MOBILITY, L.L.C.$32.5K in contracts, FY2026AI match · 100%
Reports filed in 2024, 2025.
Sources and method
Every figure on this page traces to these records.
- Bill status: bills and resolutions, sponsors, actions, subjects and CRS summaries (U.S. Government Publishing Office (GovInfo), from Congress.gov (Library of Congress))GovInfo Bill Status bulk data (Congress.gov; summaries by the Congressional Research Service) · data current to Oct 9, 2026 · loaded Oct 9, 2026 · license: Public domain (U.S. Government work, 17 U.S.C. § 105)
- Members of Congress, their terms, committees and identifiers (The @unitedstates project (from the Biographical Directory of the U.S. Congress, the House and the Senate))unitedstates/congress-legislators: legislators, committees and current committee membership · data current to Oct 3, 2026 · loaded Oct 3, 2026 · license: CC0 1.0 (public domain dedication)
- House roll-call votes (Office of the Clerk, U.S. House of Representatives)Office of the Clerk, U.S. House of Representatives, roll-call vote records · data current to Oct 3, 2026 · loaded Oct 3, 2026 · license: Public domain (U.S. Government work, 17 U.S.C. § 105)
- Senate roll-call votes and DW-NOMINATE scores (Voteview (UCLA Department of Political Science))Lewis, Jeffrey B., Keith Poole, Howard Rosenthal, Adam Boche, Aaron Rudkin, and Luke Sonnet (2026). Voteview: Congressional Roll-Call Votes Database. https://voteview.com/ · data current to Oct 3, 2026 · loaded Oct 3, 2026 · license: Free to use with the required citation
- Lobbying disclosures (LD-1 registrations, LD-2 quarterly reports, LD-203 contribution reports) (Clerk of the U.S. House of Representatives)Clerk of the House, Lobbying Disclosure Act filings (organizations only; lobbyists' names are not loaded) · data current to Oct 9, 2026 · loaded Oct 9, 2026 · license: Public domain (U.S. Government work, 17 U.S.C. § 105)
- Positions are shown only where a roll call recorded them; voice votes and unanimous consent record none.
- Money and votes are shown side by side; neither explains the other.